This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Melasma
and you are
between 20 and 60
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Tri-split face study of skin resurfacing modalities for the treatment of melasma, comparing the medium depth trichloroacetic acid peel, CO2 laser and Qs-NdYag laser.

Provided treatments

  • Drug: 22% TCA peel
  • Device: CO2 laser
  • Device: Qs-NdYag laser

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02892071. The sponsor of the trial is SUZAN OBAGI and it is looking for 0 volunteers for the current phase.
Official trial title:
Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma